A pilot study in acute subarachnoid haemorrhagic patients after aneurysm clipping with complementary therapies of Chinese medicine

Complementary Therapies in Medicine

Volumn 18, Issue 5, 2010, Pages 191-198

  Lee, Han Chung ^a,b,c   Hsieh, Ching Liang ^a,b   Chen, Chun Chung ^a   Cho, Der Yang ^a   Cheng, Kuang Fu ^b   Lin, Pao Hsuan ^b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Acute subarachnoid haemorrhage; Chinese medicine; Complementary therapies; Glasgow Outcome Scale; Total admission day

Indexed keywords

HERBACEOUS AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN S100B; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANEURYSM CLIP; ARTICLE; ASTRAGALUS MEMBRANACEUS; BODY TEMPERATURE; BRAIN ARTERY ANEURYSM; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOTOMY; EARTHWORM; FEMALE; GASTRODIA; GLASGOW OUTCOME SCALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; INTRACRANIAL PRESSURE; LENGTH OF STAY; LONICERA JAPONICA; MAJOR CLINICAL STUDY; MALE; PAEONIA SUFFRUTICOSA; PILOT STUDY; PLANT ROOT; POACEAE; RANDOMIZED CONTROLLED TRIAL; REHMANNIA; RHUBARB; SCUTELLARIA BAICALENSIS; SOUR ORANGE; SUBARACHNOID HEMORRHAGE; SURGICAL DRAINAGE; TREATMENT OUTCOME;

ADULT; AGED; ANEURYSM, RUPTURED; COMBINED MODALITY THERAPY; CYTOKINES; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; LENGTH OF STAY; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PHYTOTHERAPY; PILOT PROJECTS; SUBARACHNOID HEMORRHAGE;

EID: 78149359406     PISSN: 09652299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctim.2010.07.002     Document Type: Article

References (44)

1. van Gijn J., Rinkel G.J. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001, 124:249-278.
2. Ingall T., Asplund K., Mähönen M., Bonita R. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study. Stroke 2000, 31:1054-1061.
3. Kassell N.F., Sasaki T., Colohan A.R.T., Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985, 16(4):562-572.
4. Gui J.P. Observation of effects of salvia injection in the treatment of acute subarachnoid haemorrhage. Modern Journal of Integrated Traditional Chinese and Western Medicine 2004, 13(6):768.
5. Oliveira-Filho J., Ezzeddine M.A., Segal A.Z., Buonanno F.S., Chang Y., Ogilvy C.S., et al. Fever in subarachnoid hemorrhage: relationship to vasospasm and outcome. Neurology 2001, 56:1299-1304.
6. Commichau C., Scarmeas N., Mayer S.A. Risk factors for fever in the neurologic intensive care unit. Neurology 2003, 60:837-841.
7. Gaetani P., Pasqualin A., Baena R.R., Borasio E., Marzatico F. Oxidative stress in the human brain after subarachnoid hemorrhage. Journal of Neurosurgery 1998, 89:748-754.
8. Marik P.E. Fever in the ICU. Chest 2000, 117(3):855-869.
9. Cunha B.A. Fever in the critical care unit. Critical Care Clinics 1998, 14(1):1-14.
10. Kassell N.F., Torner J.C., Haley E.C., Jane J.A., Adams H.P., Kongable G.L., et al. The international cooperative study on the timing of aneurysm surgery. Part 1: Overall management results. Journal of Neurosurgery 1990, 73:18-36.
11. De Simoni M.G., Sironi M., De Luigi A., Manfridi A., Mantovani A., Ghezzi P. Intracerebroventricular injection of interleukin 1 induces high circulating levels of interleukin 6. Journal of Experimental Medicine 1990, 171:1773-1778.
12. Fan L., Young P.R., Barone F.C., Feuerstein G.Z., Smith D.H., McIntosh T.K. Experimental brain injury induces expression of interleukin-1β mRNA in the rat brain. Molecular Brain Research 1995, 30:125-130.
13. Holmin S., Schalling M., Höjeberg B., Nordqvist A.C.S., Skeftruna A.K., Mathiesen T. Delayed cytokine expression in rat brain following experimental contusion. Journal of Neurosurgery 1997, 86:493-504.
14. Morganti-Kossman M.C., Lenzlinger P.M., Hans V., Stahel P., Csuka E., Ammann E., et al. Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Molecular Psychiatry 1997, 2:133-136.
15. Shohami E., Ginis I., Hallenbeck J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine & Growth Factor Reviews 1999, 10:119-130.
16. Shohami E., Novikov M., Bass R., Yamin A., Gallily R. Closed head injury triggers early production of TNFα and IL-6 by brain tissue. Journal of Cerebral Blood Flow and Metabolism 1994, 14:616-619.
17. Bell M.J., Kochanek P.M., Doughty L.A., Carcillo J.A., Adelson P.D., Clark R.S.B., et al. Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. Journal of Neurotrauma 1997, 14(7):451-457.
18. Boutin H., LeFeuvre R.A., Horai R., Asano M., Iwakura Y., Rothwell N.J. Role of IL-1α and IL-1β in ischemic brain damage. The Journal of Neuroscience 2001, 21(15):5528-5534.
19. Friedlander R.M., Gagliardini V., Rotello R.J., Yuan J. Functional role of interleukin 1β (IL-1β) in IL-1β-converting enzyme-mediated apoptosis. Journal of Experimental Medicine 1996, 184:717-724.
20. Holmin S., Mathiesen T. Intracerebral administration of interleukin-1β and induction of inflammation, apoptosis, and vasogenic edema. Journal of Neurosurgery 2000, 92:108-120.
21. Bevilacqua M.P., Pober J.S., Wheeler M.E., Cotran R.S., Gimbrone M.A. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. Journal of Clinical Investigation 1985, 76:2003-2011.
22. Quagliarello V.J., Wispelwey B., Long W.J., Scheld W.M. Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat: characterization and comparison with tumor necrosis factor. Journal of Clinical Investigation 1991, 87:1360-1366.
23. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26:676-681.
24. Giulian D., Woodward J., Young D.G., Krebs J.F., Lachman L.B. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. The Journal of Neuroscience 1988, 8(7):2485-2490.
25. De Simoni M.G., De Luigi A., Gemma L., Sironi M., Manfridi A., Ghezzi P. Modulation of systemic interleukin-6 induction by central interleukin-1. American Journal of Physiology 1993, 265:R739-R742.
26. Hsieh C.L., Chen C.L., Tang N.Y., Chuang C.M., Hsieh C.T., Chiang S.Y., et al. Gastrodia elata BL mediates the suppression of nNOS and microglia activation to protect against neuronal damage in kainic acid-treated rats. The American Journal of Chinese Medicine 2005, 33(4):599-611.
27. Huang Y.H., Chang Y.M., Shen J.J., Hsieh C.L. Relationship between the anticonvulsion effect of Gastrodia elata and interleukin-1β, tumor necrosis factor-α and nitric oxide. Mid-Taiwan Journal of Medicine 2005, (Suppl. 10):S1-S8.
28. Hsieh C.L., Cheng C.Y., Tsai T.H., Kin I.H., Liu C.H., Chiang S.Y., et al. Paeonol reduced cerebral infarction involving the superoxide anion and microglia activation in ischemia-reperfusion injured rats. Journal of Ethnopharmacology 2006, 106:208-215.
29. Hunt W.E., Hess R.M. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. Journal of Neurosurgery 1968, 28(1):14-20.
30. Bederson J.B., Connolly E.S., Batjer H.H., Dacey R.G., Dion J.E., Diringer M.N., et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 2009, 40:994.
31. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1(7905):480-484.
32. Hsieh C.L., Chang C.H., Chiang S.Y., Li T.C., Tang N.Y., Pon C.Z., et al. Anticonvulsive and free radical scavenging activities of vanillyl alcohol in ferric chloride-induced epileptic seizures in Sprague-Dawley rats. Life Sciences 2000, 67:1185-1195.
33. Hsieh C.L., Chiang S.Y., Cheng K.S., Lin Y.H., Tang N.Y., Lee C.J., et al. Anticonvulsive and free radical scavenging activities of Gastrodia elata BL in kainic acid-treated rats. The American Journal of Chinese Medicine 2001, 29(2):331-341.
34. Luo Y., Qin Z., Hong Z., Zhang X., Ding D., Fu J.H., et al. Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia. Neuroscience Letters 2004, 363:218-223.
35. Wu X., Huang Y. Review of experimental research on Calamus chemical components functional mechanism on CNS. Journal of ZheJiang University of Traditional Chinese Medicine 2007, 31(6):789-791.
36. Ji H., Wang L., Bi H., Sun L., Cai B., Wang Y., et al. Mechanisms of lumbrokinase in protection of cerebral ischemia. European Journal of Pharmacology 2008, 590:281-289.
37. Chen H.Q., Jin Z.Y., Wang X.J., Xu X.M., Deng L., Zhao J.W. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neuroscience Letters 2008, 448:175-179.
38. Chen C.Y., Peng W.H., Tsai K.D., Hsu S.L. Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophage. Life Sciences 2007, 81:1602-1614.
39. +-induced oxidative stress in mesencephalic neurons. European Journal of Pharmacology 2007, 568:142-148.
40. 2-induced oxidative stress in astrocytes primary cultures. Neuroscience Letters 2008, 442:224-227.
41. Li B.Q., Fu T., Gong W.H., Dunlop N., Kung H.F., Yan Y., et al. The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines. Immunopharmacology 2000, 49:295-306.
42. He X.L., Wang Y.H., Gao M., Li X.X., Zhang T.T., Du G.H. Baicalein protects rat brain mitochondria against chronic cerebral hypoperfusion-induced oxidative damage. Brain Research 2009, 1249:212-221.
43. Huang Q., Shen H.M., Ong C.N. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-κB. Biochemical Pharmacology 2004, 68:361-371.
44. Su M.S., Shyu Y.T., Chien P.J. Antioxidant activities of citrus herbal product extracts. Food Chemistry 2008, 111:892-896.